
Rapt Therapeutics Inc
NASDAQ:RAPT

US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.984
30
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

Intrinsic Value
The intrinsic value of one
RAPT
stock under the Base Case scenario is
5.92
USD.
Compared to the current market price of 8.62 USD,
Rapt Therapeutics Inc
is
Overvalued by 31%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Rapt Therapeutics Inc
Loading...
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
US |
E
|
Epizyme Inc
F:EPE
|
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
US |
S
|
Seagen Inc
F:SGT
|
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:


Revenue & Expenses Breakdown
Rapt Therapeutics Inc
Balance Sheet Decomposition
Rapt Therapeutics Inc
Current Assets | 183m |
Other Current Assets | 183m |
Non-Current Assets | 5m |
PP&E | 4m |
Other Non-Current Assets | 1m |
Current Liabilities | 8.7m |
Accounts Payable | 1.3m |
Accrued Liabilities | 7.2m |
Other Current Liabilities | 140k |
Non-Current Liabilities | 1.3m |
Other Non-Current Liabilities | 1.3m |
Free Cash Flow Analysis
Rapt Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Rapt Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-122m
USD
|
Operating Income
|
-122m
USD
|
Other Expenses
|
6m
USD
|
Net Income
|
-116m
USD
|
RAPT Profitability Score
Profitability Due Diligence
Rapt Therapeutics Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Score
Rapt Therapeutics Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
RAPT Solvency Score
Solvency Due Diligence
Rapt Therapeutics Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Score
Rapt Therapeutics Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RAPT Price Targets Summary
Rapt Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
RAPT
is 30.6 USD
with a low forecast of 8.08 USD and a high forecast of 50.4 USD.
Dividends
Current shareholder yield for RAPT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RAPT
stock under the Base Case scenario is
5.92
USD.
Compared to the current market price of 8.62 USD,
Rapt Therapeutics Inc
is
Overvalued by 31%.